• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型及新兴药物治疗儿科癫痫

New and Emerging Medications for Treatment of Pediatric Epilepsy.

机构信息

Cook Children's Medical Center, Fort Worth, Texas.

出版信息

Pediatr Neurol. 2020 Jun;107:24-27. doi: 10.1016/j.pediatrneurol.2019.11.008. Epub 2019 Nov 29.

DOI:10.1016/j.pediatrneurol.2019.11.008
PMID:31980296
Abstract

BACKGROUND

Multiple medications have recently been approved or are nearing US Food and Drug Administration approval for treatment of pediatric epilepsy, while a number of other compounds are in development. Many of these therapies are seeking indications in rare epilepsy syndromes and present novel mechanisms of action for the treatment of epilepsy.

METHODS

Data related to drugs in development or under study were accessed following literature search via PubMed or author knowledge of publically available data.

RESULTS

Several new compounds are recently approved or under study for epilepsy in children.

CONCLUSIONS

The following is a brief overview of the new and emerging medications for the treatment of pediatric epilepsy.

摘要

背景

最近已有多种药物获得美国食品和药物管理局批准或即将获得批准,用于治疗儿科癫痫,而其他许多化合物也正在开发中。 许多这些疗法都在寻求罕见癫痫综合征的适应症,并为癫痫治疗提供新的作用机制。

方法

通过 PubMed 文献检索或作者对公开可用数据的了解,获取有关正在开发或研究中的药物的数据。

结果

最近有几种新的化合物被批准或正在研究用于治疗儿童癫痫。

结论

以下是治疗小儿癫痫的新出现药物的简要概述。

相似文献

1
New and Emerging Medications for Treatment of Pediatric Epilepsy.新型及新兴药物治疗儿科癫痫
Pediatr Neurol. 2020 Jun;107:24-27. doi: 10.1016/j.pediatrneurol.2019.11.008. Epub 2019 Nov 29.
2
Dravet Syndrome: A Review of Current Management.德拉韦特综合征:当前管理的综述。
Pediatr Neurol. 2020 Jun;107:28-40. doi: 10.1016/j.pediatrneurol.2020.01.005. Epub 2020 Jan 31.
3
Changing Landscape of Dravet Syndrome Management: An Overview.Dravet 综合征管理现状的改变:概述。
Neuropediatrics. 2020 Apr;51(2):135-145. doi: 10.1055/s-0040-1701694. Epub 2020 Feb 20.
4
Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy.甘氨酰胺在难治性癫痫儿童和青少年患者中的临床评估。
Epilepsia. 2007 Oct;48(10):1870-4. doi: 10.1111/j.1528-1167.2007.01182.x. Epub 2007 Jul 18.
5
Cannabidiol for Epilepsy: New Hope on the Horizon?大麻二酚治疗癫痫:新希望即将出现?
Clin Ther. 2018 Sep;40(9):1438-1441. doi: 10.1016/j.clinthera.2018.07.020. Epub 2018 Aug 25.
6
Stiripentol for the treatment of seizures in Dravet syndrome.司替戊醇治疗 Dravet 综合征的癫痫发作。
Expert Rev Clin Pharmacol. 2019 May;12(5):379-388. doi: 10.1080/17512433.2019.1605904. Epub 2019 Apr 24.
7
Lennox-Gastaut syndrome: New treatments and treatments under investigation. Lennox-Gastaut 综合征:新的治疗方法和正在研究的治疗方法。
Rev Neurol (Paris). 2020 Jun;176(6):444-447. doi: 10.1016/j.neurol.2020.01.364. Epub 2020 May 11.
8
Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US.长期安全性、耐受性和疗效的大麻二酚在儿童难治性癫痫:结果从一个扩大获得程序在美国。
CNS Drugs. 2019 Jan;33(1):47-60. doi: 10.1007/s40263-018-0589-2.
9
Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center.大麻二酚手工制剂治疗癫痫的疗效:三级医疗中心的实践经验。
Epilepsy Behav. 2018 Mar;80:240-246. doi: 10.1016/j.yebeh.2018.01.026. Epub 2018 Feb 9.
10
Thrombocytopenia in pediatric patients on concurrent cannabidiol and valproic acid.儿童患者同时使用大麻二酚和丙戊酸时出现血小板减少症。
Epilepsia. 2020 Aug;61(8):e85-e89. doi: 10.1111/epi.16596. Epub 2020 Jul 2.

引用本文的文献

1
New Pharmacological Therapies in the Treatment of Epilepsy in the Pediatric Population.治疗儿童癫痫的新型药物疗法
J Clin Med. 2024 Jun 18;13(12):3567. doi: 10.3390/jcm13123567.
2
Knowledge and Attitude of Saudi Physicians Toward Cannabidiol for Pediatric Epilepsy: A Cross-Sectional Study.沙特医生对用于小儿癫痫的大麻二酚的知识与态度:一项横断面研究。
Cureus. 2023 Mar 24;15(3):e36622. doi: 10.7759/cureus.36622. eCollection 2023 Mar.
3
Novel neurosteroid pregnanolone pyroglutamate suppresses neurotoxicity syndrome induced by tetramethylenedisulfotetramine but is ineffective in a rodent model of infantile spasms.
新型神经甾体化合物吡咯烷酮孕烷醇酮可抑制四亚甲基二砜四胺诱导的神经毒性综合征,但对婴儿痉挛症的啮齿动物模型无效。
Pharmacol Rep. 2023 Feb;75(1):177-188. doi: 10.1007/s43440-022-00437-1. Epub 2022 Nov 23.
4
On disturbance rejection control of the epileptiform spikes.关于癫痫样尖峰的干扰抑制控制
Cogn Neurodyn. 2022 Apr;16(2):425-441. doi: 10.1007/s11571-021-09704-y. Epub 2021 Sep 22.
5
From a Symptom-Based to a Mechanism-Based Pharmacotherapeutic Treatment in Complex Regional Pain Syndrome.从基于症状的治疗到基于机制的复杂区域疼痛综合征药物治疗。
Drugs. 2022 Apr;82(5):511-531. doi: 10.1007/s40265-022-01685-4. Epub 2022 Mar 5.
6
New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment.癫痫治疗的新趋势与最具前景的治疗策略
Front Neurol. 2021 Dec 7;12:753753. doi: 10.3389/fneur.2021.753753. eCollection 2021.
7
GABAkines - Advances in the discovery, development, and commercialization of positive allosteric modulators of GABA receptors.GABAkines- GABA 受体正向变构调节剂的发现、开发和商业化进展。
Pharmacol Ther. 2022 Jun;234:108035. doi: 10.1016/j.pharmthera.2021.108035. Epub 2021 Nov 16.
8
Neurosteroids and Seizure Activity.神经甾体与癫痫发作活动。
Front Endocrinol (Lausanne). 2020 Sep 30;11:541802. doi: 10.3389/fendo.2020.541802. eCollection 2020.